Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Articles: Therapeutics, Targets, and Development

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors

Emma Kulimova, Elisabeth Oelmann, Guido Bisping, Joachim Kienast, Rolf M. Mesters, Joachim Schwäble, Frank Hilberg, Gerald J. Roth, Gerd Munzert, Martin Stefanic, Björn Steffen, Christian Brandts, Carsten Müller-Tidow, Astrid Kolkmeyer, Thomas Büchner, Hubert Serve and Wolfgang E. Berdel
Emma Kulimova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Oelmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Bisping
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Kienast
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf M. Mesters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Schwäble
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Hilberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald J. Roth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerd Munzert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Stefanic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Björn Steffen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Brandts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Müller-Tidow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Astrid Kolkmeyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Büchner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubert Serve
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang E. Berdel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-06-0323 Published December 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

In acute myeloid leukemia (AML), receptor tyrosine kinase ligands promote growth and survival and contribute to AML-associated marrow neoangiogenesis. We have tested simultaneous inhibition of vascular endothelial growth factor, fibroblast growth factor, and platelet-derived growth factor receptor signaling by novel indolinone derivatives using 14 myeloid, including 11 human leukemic, cell lines. Compounds inhibited colony formation of all cell lines in a dose-dependent fashion. Inhibitory concentrations for 50% of the colony formation/survival (IC50) for BIBF1000 were <100 nmol/L for 3 of 11, ≤500 nmol/L for 6 of 11, and <1,000 nmol/L for 10 of 11 leukemic cell lines, with one cell line being resistant in the dose range <1,000 nmol/L. BIBF1120 was less effective with 4 of 11 leukemic cell lines being resistant within the dose range <1,000 nmol/L. Testing of myeloid 32D cells transfected with empty vector, wild-type Flt3, or Flt3 carrying an internal tandem duplication mutation revealed higher resistance for the internal tandem duplication mutant. These effects of the compounds were associated with inhibition of tyrosine phosphorylation and the mitogen-activated protein kinase pathway. Furthermore, both compounds induced apoptosis in the sensitive cell lines. In Mono-Mac1 cells, the compounds had a direct proapoptotic effect that was increasing the proapoptotic effect of 1-β-d-arabinofuranosylcytosine. The data provide a rationale for clinical evaluation of these tyrosine kinase inhibitors in AML. [Mol Cancer Ther 2006;5(12):3105–12]

Keywords:
  • AML
  • VEGF
  • bFGF
  • receptor tyrosine kinases

Footnotes

  • Grant support: Boehringer Ingelheim, Germany.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Note: E. Kulimova and E. Oelmann contributed equally as first authors. E. Kulimova has obtained a fellowship from the European Society for Medical Oncology.

    • Accepted October 27, 2006.
    • Received May 31, 2006.
    • Revision received September 25, 2006.
  • American Association for Cancer Research
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 5 (12)
December 2006
Volume 5, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
Citation Tools
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
Emma Kulimova, Elisabeth Oelmann, Guido Bisping, Joachim Kienast, Rolf M. Mesters, Joachim Schwäble, Frank Hilberg, Gerald J. Roth, Gerd Munzert, Martin Stefanic, Björn Steffen, Christian Brandts, Carsten Müller-Tidow, Astrid Kolkmeyer, Thomas Büchner, Hubert Serve and Wolfgang E. Berdel
Mol Cancer Ther December 1 2006 (5) (12) 3105-3112; DOI: 10.1158/1535-7163.MCT-06-0323

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
Emma Kulimova, Elisabeth Oelmann, Guido Bisping, Joachim Kienast, Rolf M. Mesters, Joachim Schwäble, Frank Hilberg, Gerald J. Roth, Gerd Munzert, Martin Stefanic, Björn Steffen, Christian Brandts, Carsten Müller-Tidow, Astrid Kolkmeyer, Thomas Büchner, Hubert Serve and Wolfgang E. Berdel
Mol Cancer Ther December 1 2006 (5) (12) 3105-3112; DOI: 10.1158/1535-7163.MCT-06-0323
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
  • Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs
  • Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Show more Research Articles: Therapeutics, Targets, and Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement